Bexinib 1mg Tablet

Bexinib 1mg Tablet is an anticancer drug belonging to the class of tyrosine kinase inhibitors, containing the active ingredient Axitinib. It is used to treat advanced kidney cancer which is also known as renal cell carcinoma that originates in the cells of the kidney. It is not recommended to undergo surgical procedure while on treatment with Bexinib 1mg Tablet due to high risk of bleeding. Tell your physician before you undergo surgery or dental procedures. Get immediate medical attention if you experience itching, vision changes, confusion or dizziness. This medicine may cause harm to an unborn baby. Tell your healthcare provider before beginning this treatment if you are pregnant or planning to have a baby. It is advised for both men and women to follow proper contraceptive methods during and one week after the last dose of Bexinib 1mg Tablet. Avoid breastfeeding your baby while you are on the treatment as Bexinib 1mg Tablet can impact the growth and development of the baby by passing into the breast milk. If you get mouth sores, weight loss, and have itchy skin, consult with your doctor. Bexinib 1mg Tablets are not recommended for adolescents and children under the age of 18. Contact your doctor immediately if you experience shortness of breath, chest pain or worsening cough. During the Bexinib 1mg Tablet treatment, your doctor may periodically monitor your white blood cell counts, platelets, blood sugar, electrolytes and kidney parameters to prevent serious complications. Some GI symptoms may also develop during the treatment such as diarrhea, nausea, vomiting, and constipation. It is necessary to report to your doctor right away.